Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 244.65
-9.60 (-3.78%)
Aug 1, 2025, 3:30 PM IST
Smartsheet Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 38.36 billion as of August 1, 2025. Its market cap has increased by 45.67% in one year.
Market Cap
38.36B
Enterprise Value
56.92B
Revenue
27.12B
Ranking
n/a
PE Ratio
1,183.86
Stock Price
$244.65
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 38.36B, a decrease of -32.49%. That is a compound annual growth rate of -4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 38.36B | -9.55% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | 21.76B | 59.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,094.94B |
| Divi's Laboratories | 1,750.90B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.56B |
| Zydus Lifesciences | 975.85B |
| Fortis Healthcare | 647.34B |
| Aurobindo Pharma | 627.15B |